Connect with Delim at CPHI Milan

Milan, Italy: – Innovative CRO Delim Cosmetics & Pharma s.r.l. will of course be present at Europe’s leading pharma industry event, the CPHI 2024 trade expo, this year in Delim’s home city of Milan.

Delim will send a team as visitors to the show, ready to take part in the event’s many networking opportunities, as it seeks to expand its network of academic and commercial partners and develop new collaborations.

Scientific advances

The Delim team in Milan will be able to talk about its recent advances in overcoming scientific challenges to develop innovative topical and other formulations for a wide range of therapeutic indications as well as cosmeceutical applications.

Examples include a QbD approach to the development of a generic Adapalene topical gel formulation therapeutically equivalent to an RLD for treatment of acne vulgaris skin conditions and a recent collaboration with another Italian pharmaceutical company to develop a cholinergic orodispersible granulate drug for the treatment of cognitive decline.

About Delim

Headquartered at Vimodrone, in Milan, Delim Cosmetics & Pharma s.r.l., has rapidly established itself as a dynamic and innovative Contract Research Organisation (CRO) specializing in the development of novel drugs formulations and generic pharmaceutical products.

Delim specializes in the design, patenting, and technical transfer of innovative and generic pharmaceutical products in line with its core mission to offer highly advanced B2B services to companies that need innovative technical/scientific support for the development of pharmaceutical products.

Delim services include assistance for: patenting, sourcing of API active ingredients, development of prototypes, clinical trials. Also, assistance for: scale-up of manufacturing methods, tech transfer to GMP facilities, production of pilot, validation and bio batches, regulatory consulting and preparation of dossiers for pharmaceutical products registration.

Delim’s in-house specialist expertise takes in development of semi-solid innovative and generic formulations (Q1, Q2, Q3), solid oral formulations for both immediate release and controlled release through technologies such as fluid bed coating and spray drying, in vitro studies of semi-solid products for topical and ophthalmic use, and development and validation of analytical methods.

Its technology portfolio covers a broad range of therapeutic areas and delivery systems including dermatology, gynecology, pneumology, oncology, and ophthalmology. It also specializes in formulations for medical device delivery in additional application areas such as orthopedics and aesthetic medicine.

To learn more, visit: https://www.delim.it/

About CPHI Milan 2024

Now in its 35th year, CPHI continues as the flagship European annual trade show for pharma ingredients and partner sourcing, with a refreshed mission to be the industry’s main enabler for sustainability, whilst also being an environmentally and socially responsible event.

The recently rebranded expo now uses a hybrid model that fuses one of Europe’s largest physical expos with an online dimension to make networking and browsing easier and to extend the time frame of the event indefinitely.

For 2024, CPHI Milan is a three-day event opening October 8 at the Fiera Milan convention center, with the online dimension now accessible all year round.

The newly integrated main CPHI event features exhibitor zones for Machinery & Equipment, Finished Dosage, Packaging & Drug Delivery, Contract Manufacturing & Services, APIs, Excipients, Integrated Pharma, Natural extracts, and Fine Chemicals

CPHI Milan is organised by Informa Markets with further information at: https://www.cphi.com/europe/en/home.html

Resources

Click on Delim Pharmaceutical Services for further information.